Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke
NCT07682922Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 4 trial of edaravone dexborneol in ischemic stroke, sponsored by Xinqiao Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07682922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682922.